Multiple Sclerosis
Conference Coverage
Can supplementary estrogen relieve MS symptoms in menopausal women?
Research suggests lowered hormone levels may worsen the disease.
Literature Review
Neurologic drug prices jump 50% in five years
Most of the increased cost was due to rising costs for neuroimmunology drugs, mainly for those used to treat multiple sclerosis (MS).
Conference Coverage
Sun exposure linked to reduced pediatric MS risk
Children should spend at least 30 minutes outdoors in the sun every day, while using adequate sun protection.
Conference Coverage
Erythropoietin falls short of neuroprotection in optic neuritis
“EPO conveyed neither functional nor structural neuroprotection in the visual pathways after optic neuritis as a clinically isolated syndrome.”
Conference Coverage
Disease progression and therapy response vary in MS by ethnicity
African Americans and Hispanics had more severe illness than Caucasians, and there were other differences as well.
Conference Coverage
Newly approved drugs offer new hope in NMOSD
Trio of medications offer relief from relapses, neurologist tells colleagues
Conference Coverage
Infections – especially urinary and kidney – are higher in MS
Among patients with MS, the infection rate was more than quadruple the rate in a control cohort.
Conference Coverage
Anti-CD20s linked to higher COVID-19 severity in MS
Older age and disability are also linked to extra risk, registries find, but not other DMTs.
Conference Coverage
Certain DMTs in MS may attenuate COVID-19 vaccines
Adjust timing if feasible, neurologist says, but focus on getting shots in arms.
Conference Coverage
Natalizumab postinfusion reactions rare; is monitoring necessary?
New findings “highlight a potential opportunity to improve and streamline the infusion and post-infusion monitoring process.”